Pulmonary Fibrosis Due to COVID-19
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis Due to COVID-19.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu [Phase 2]
Phase 2 clinical trial on Fuzheng Huayu for pulmonary fibrosis due to COVID-19 has completed.